Clinical Trials, Phase III as Topic
"Clinical Trials, Phase III as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
MeSH Number(s)
E05.318.760.535.220
E05.337.250.220
N05.715.360.775.235.220
N06.850.520.450.535.220
Below are MeSH descriptors whose meaning is more general than "Clinical Trials, Phase III as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials, Phase III as Topic".
This graph shows the total number of publications written about "Clinical Trials, Phase III as Topic" by people in Harvard Catalyst Profiles by year, and whether "Clinical Trials, Phase III as Topic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1993 | 0 | 1 | 1 |
| 1994 | 1 | 1 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 2 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 10 | 10 |
| 2002 | 3 | 7 | 10 |
| 2003 | 3 | 5 | 8 |
| 2004 | 4 | 7 | 11 |
| 2005 | 2 | 15 | 17 |
| 2006 | 3 | 11 | 14 |
| 2007 | 0 | 13 | 13 |
| 2008 | 5 | 25 | 30 |
| 2009 | 4 | 16 | 20 |
| 2010 | 4 | 19 | 23 |
| 2011 | 2 | 26 | 28 |
| 2012 | 6 | 21 | 27 |
| 2013 | 11 | 22 | 33 |
| 2014 | 8 | 21 | 29 |
| 2015 | 0 | 18 | 18 |
| 2016 | 6 | 26 | 32 |
| 2017 | 6 | 30 | 36 |
| 2018 | 9 | 33 | 42 |
| 2019 | 4 | 33 | 37 |
| 2020 | 0 | 19 | 19 |
Below are the most recent publications written about "Clinical Trials, Phase III as Topic" by people in Profiles.
-
Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis. JAMA Oncol. 2020 12 01; 6(12):e204930.
-
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol. 2020 12; 21(12):1620-1629.
-
Efficacy of intravenous NEPA, a fixed NK1/5-HT3 receptor antagonist combination, for the prevention of chemotherapy-induced nausea and vomiting (CINV) during cisplatin- and anthracycline cyclophosphamide (AC)-based chemotherapy: A review of phase 3 studies. Crit Rev Oncol Hematol. 2021 Jan; 157:103143.
-
Targeting HER2 heterogeneity in early-stage breast cancer. Curr Opin Oncol. 2020 11; 32(6):545-554.
-
Understanding COVID-19 vaccine efficacy. Science. 2020 11 13; 370(6518):763-765.
-
COVID-19 Vaccines: Current Status and Implication for Use in Indonesia. Acta Med Indones. 2020 Oct; 52(4):388-412.
-
"When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination. N Engl J Med. 2020 Dec 03; 383(23):2202-2204.
-
Missed Opportunities on Emergency Remdesivir Use. JAMA. 2020 07 28; 324(4):331-332.
-
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design. Am Heart J. 2020 11; 229:61-69.
-
Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an effectiveness-implementation cluster randomized trial. Trials. 2020 Jun 09; 21(1):509.